We hypothesized that an increased level of intestinal ME1 would promote intestinal cell proliferation and lipogenic pathway gene expression, as well as induce metabolic alterations and predisposition to obesity and hepatosteatosis. The gene discussed is ME1; the disease is obesity due to melanocortin 4 receptor deficiency.